Mutations in theRUNX2 gene in patients with cleidocranial dysplasia
- 13 February 2002
- journal article
- review article
- Published by Hindawi Limited in Human Mutation
- Vol. 19 (3), 209-216
- https://doi.org/10.1002/humu.10043
Abstract
Cleidocranial dysplasia (CCD) is a autosomal dominant disorder characterized by skeletal anomalies such as patent fontanels, late closure of cranial sutures with Wormian bones, late erupting secondary dentition, rudimentary clavicles, and short stature. The locus for this disease was mapped to chromosome 6p21. RUNX2 is a member of the runt family of transcription factors and its expression is restricted to developing osteoblasts and a subset of chondrocytes. Mutations in the RUNX2 gene have been shown to cause CCD. Chromosomal translocations, deletions, insertions, nonsense and splice‐site mutations, as well as missense mutations of the RUNX2 gene have been described in CCD patients. Although there is a wide spectrum in phenotypic variability ranging from primary dental anomalies to all CCD features plus osteoporosis, no clear phenotype–genotype correlation has been established. However analysis of the three‐dimensional structure of the DNA binding runt domain of the RUNX proteins and its interaction with DNA, as well as the cofactor CBFB, start to provide an insight into how missense mutations affect RUNX2 function. Hum Mutat 19:209–216, 2002.Keywords
This publication has 31 references indexed in Scilit:
- Biophysical characterization of interactions between the core binding factor α and β subunits and DNAFEBS Letters, 2000
- AML3/CBFα1 Is Required for Androgen-specific Activation of the Enhancer of the Mouse Sex-limited Protein (Slp) GeneJournal of Biological Chemistry, 1999
- Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormoneOncogene, 1999
- Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasiaNature Genetics, 1997
- ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function.Genes & Development, 1997
- Genetic mapping of the cleidocranial dysplasia (CCD) locus on chromosome band 6p21 to include a microdeletionAmerican Journal of Medical Genetics, 1995
- Cleidocranial dysplasia associated with a t(6;18)(p12;q24) translocationAmerican Journal of Medical Genetics, 1995
- Pericentric inversion of chromosome 6 in a patient with cleidocranial dysplasiaAmerican Journal of Medical Genetics, 1993
- Apparent cleidocranial dysplasia associated with abnormalities of 8q22 in three individualsAmerican Journal of Medical Genetics, 1992
- Intrafamilial variability in cleidocranial dysplasia: A three generation familyAmerican Journal of Medical Genetics, 1992